Return to homepagePandemic Pact

High definition immunomonitoring & characterization of specific antibodies in critical CoV-2 patients versus in remission]

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $237,892.68

  • Funder

    Other funders (France)

  • Principal Investigator

    Michel COGNE

  • Research Location

    France

  • Lead Research Institution

    Etablissement Français du Sang de Bretagne, Rennes

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Immunity

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

The HARMONICOV project consists of precisely studying the body's immune response to infection with the Sars-CoV2 virus in order to reveal prognostic and therapeutic biomarkers, useful in patient monitoring. This work will also participate in the identification of antibodies that will be used in the development of immunotherapy against the virus.